Replies to post #520047 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

NWBO extended because they did not have good enough data.

Bullshit. Doctors, experts and the data itself clearly disagree.

Yesterday you backed up your conclusory statement by pointing out that you were an IT expert with an IT background. Can you let me know the basis to the above conclusory statement? TIA!

Have a great one pal! by.

[DrHigh]

It's a cancer trial with the deadliest form of cancer. the fact alone that cancer patients lived long enough so NWBO could deal with crossover, pseudo progression issues etc is a great sign. spin all you want but patients are living longer. that is good for humanity and disgusting that you disagree.

[supersteve13]

I agree that the survival benefit for GBM and rGBM is impressive, and like you I look forward to the extension of this therapeutic regimen to the GBM patient population at large! I’m glad that we all want what’s best for patients and that no one here intentionally tries to downplay the success for financial reasons.

[Dr Bala]

Checkmating after highly successful GBM P3 trial is an impossible task.